U-Blot® Research Grade Anti-Human CD73/NT5E (INCA00186)Cat. No. WA1780Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD73/NT5E (INCA00186)Cat. No. WA1780
U-Blot® Research Grade Anti-Human CD73/NT5E (IBI-325)Cat. No. WA1779
U-Blot® Research Grade Anti-Human CD73/NT5E (CM 326)Cat. No. WA1778
U-Blot® Research Grade Anti-Human CD73/NT5E (BMS-986179)Cat. No. WA1777
U-Blot® Research Grade Anti-Human CD73/NT5E (BC010)Cat. No. WA1776
U-Blot® Research Grade Anti-Human CD71/TFRC (TXB4)Cat. No. WA1775
U-Blot® Research Grade Anti-Human CD71/TFRC (TSP-A18)Cat. No. WA1774
U-Blot® Research Grade Anti-Human CD71/TFRC (JST-TFR09)Cat. No. WA1773
U-Blot® Research Grade Anti-Human CD71/TFRC (INA01)Cat. No. WA1772
U-Blot® Research Grade Anti-Human CD71/TFRC (CX-2029)Cat. No. WA1771
U-Blot® Research Grade Anti-Human CD71/TFRC (AOC 1001)Cat. No. WA1770
U-Blot® Research Grade Anti-Human CD71/TFRC (AbGn-107)Cat. No. WA1769